Helix Nano
Helix Nano is a biotechnology company developing next-generation mRNA technologies, vaccines, and therapies designed to enhance the immune system's ability to fight diseases. Founded by CEO Hannu Rajaniemi and CSO Nikolai Eroshenko, the company focuses on innovative approaches to molecular engineering and immunological research.
Year Invested
2024
Industry
Artificial Intelligence
Status
Active